Suppr超能文献

火龙罐预防和治疗乳腺癌化疗所致恶心呕吐的随机对照试验

[Fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting in breast cancer: a randomized controlled trial].

作者信息

Chen Qingqing, Lei Yeyan, Bai Shuang, Luo Xujin, Lei Xinyun, Chen Yanping, Li Dongmei

机构信息

Department of Galactophore, Zhuhai Hospital, Guangdong Provincial Hospital of TCM,Zhuhai 519000, China.

出版信息

Zhongguo Zhen Jiu. 2024 May 12;44(5):526-30. doi: 10.13703/j.0255-2930.20230712-k0005.

Abstract

OBJECTIVE

To observe the clinical efficacy and safety of fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in breast cancer.

METHODS

Sixty breast cancer patients receiving medium-high emetogenic chemotherapy regimen were randomly divided into an observation group (30 cases, 3 cases dropped out) and a control group (30 cases, 3 cases dropped out). In both groups, 5 mg tropisetron hydrochloride was given intravenously on the day of chemotherapy and 1st to 3rd days after chemotherapy. In the observation group, fire dragon cupping on the abdomen was applied on 1st, 3rd and 5th days after chemotherapy. The incidence of nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, the severity of nausea, vomiting on 1st to 6th days after chemotherapy, and the duration of nausea, vomiting, loss of appetite were observed in the two groups. The self-rating anxiety scale (SAS) score, general comfort questionnaire scale (GCQ) score before and after treatment and remedy antiemetic medication were observed in the two groups, and the safety was evaluated.

RESULTS

On 2nd to 6th days after chemotherapy, the number of patients with nausea, loss of appetite and abdominal distension and nausea scores in the observation group were lower than those in the control group (<0.05). On 1st to 3rd days after chemotherapy, the number of patients with vomiting and vomiting scores in the observation group were lower than those in the control group (<0.05). The duration of nausea, vomiting and loss of appetite in the observation group were shorter than those in the control group (<0.05). In the observation group, there was no significant difference in SAS and GCQ scores before and after treatment (>0.05). After treatment, the GCQ score in the control group was decreased compared with that before treatment (<0.05). After treatment, there was no significant difference in SAS and GCQ scores between the two groups (>0.05). There was no significant difference in the number of patients using remedy medication between the two groups (>0.05). No adverse reaction occurred during treatment in both groups.

CONCLUSION

Fire dragon cupping can effectively reduce the incidence of nausea, vomiting, loss of appetite and the severity of nausea, vomiting related to chemotherapy in breast cancer, and improve patient comfort, and have good safety.

摘要

目的

观察火龙罐在预防和治疗乳腺癌化疗所致恶心呕吐(CINV)中的临床疗效及安全性。

方法

将60例接受中高致吐性化疗方案的乳腺癌患者随机分为观察组(30例,脱落3例)和对照组(30例,脱落3例)。两组均在化疗当天及化疗后第1至3天静脉注射5 mg盐酸托烷司琼。观察组在化疗后第1、3、5天对腹部进行火龙罐治疗。观察两组化疗后第1至6天恶心、呕吐、食欲不振、腹痛、腹胀的发生率,恶心、呕吐的严重程度,以及恶心、呕吐、食欲不振的持续时间。观察两组治疗前后的自评焦虑量表(SAS)评分、一般舒适度问卷量表(GCQ)评分及补救性止吐药物使用情况,并评估安全性。

结果

化疗后第2至6天,观察组恶心、食欲不振、腹胀患者人数及恶心评分低于对照组(<0.05)。化疗后第1至3天,观察组呕吐患者人数及呕吐评分低于对照组(<0.05)。观察组恶心、呕吐、食欲不振的持续时间短于对照组(<0.05)。观察组治疗前后SAS、GCQ评分差异无统计学意义(>0.05)。对照组治疗后GCQ评分较治疗前降低(<0.05)。治疗后,两组SAS、GCQ评分差异无统计学意义(>0.05)。两组补救性用药患者人数差异无统计学意义(>0.05)。两组治疗期间均未发生不良反应。

结论

火龙罐能有效降低乳腺癌化疗相关恶心、呕吐、食欲不振的发生率及恶心、呕吐的严重程度,提高患者舒适度,且安全性良好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验